These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5447172)

  • 41. [Standardization as a basis for planning and administration in drug industry and pharmacy (I)].
    Koch H
    Pharm Prax; 1970; 7():147-51. PubMed ID: 5469873
    [No Abstract]   [Full Text] [Related]  

  • 42. [The true face of the capitalistic world. Monopoly and drugs].
    Voevodin E
    Pharm Prax; 1966; 5():119-20. PubMed ID: 5986226
    [No Abstract]   [Full Text] [Related]  

  • 43. [Czechoslovak mass-produced pharmaceutical preparations--their number and internal composition. IV].
    Dofková L; Precechtĕlová E; Malír F
    Cesk Farm; 1979 Feb; 28(1):6-10. PubMed ID: 455500
    [No Abstract]   [Full Text] [Related]  

  • 44. [Drug samples for physicians].
    Schulz G
    Ther Ggw; 1969 Feb; 108(2):299-302. PubMed ID: 5792520
    [No Abstract]   [Full Text] [Related]  

  • 45. Securing the US pharmaceutical supply.
    Somberg JC
    Am J Ther; 2008; 15(3):197. PubMed ID: 18496255
    [No Abstract]   [Full Text] [Related]  

  • 46. [Determination of requirements and planning of drug readiness in the field of drug supply].
    Dittes W
    Pharm Prax; 1967; 4():73-81. PubMed ID: 5599827
    [No Abstract]   [Full Text] [Related]  

  • 47. Adopting orphan drugs: Congress tries to encourage new remedies for rare diseases.
    Wallis C
    Time; 1982 Oct; 120(15):76, 79. PubMed ID: 10317248
    [No Abstract]   [Full Text] [Related]  

  • 48. No shortage of blame. Congress refocuses on gray market in drug shortfalls.
    Lee J
    Mod Healthc; 2012 Jul; 42(31):8-9. PubMed ID: 22950221
    [No Abstract]   [Full Text] [Related]  

  • 49. Spurious and counterfeit drugs: a growing industry in the developing world.
    Gautam CS; Utreja A; Singal GL
    Postgrad Med J; 2009 May; 85(1003):251-6. PubMed ID: 19520877
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [PRESENT EXPERIENCES WITH THE STABILITY OF DRUGS IN THE PHARMACEUTICAL INDUSTRY].
    PALKOSKA J
    Cesk Farm; 1963 Dec; 12():520-3. PubMed ID: 14118729
    [No Abstract]   [Full Text] [Related]  

  • 51. [The place of drugs in health economics].
    Sigvard J
    Therapie; 1977; 32(5):529-52. PubMed ID: 349766
    [No Abstract]   [Full Text] [Related]  

  • 52. Increased direct-to-consumer advertising driving pharmaceutical costs, trends.
    Fine A
    Exec Solut Healthc Manag; 1999 Jan; 2(1):2-3. PubMed ID: 10345986
    [No Abstract]   [Full Text] [Related]  

  • 53. Issues in bringing new drugs to the market.
    Tracey WR
    Science; 2005 Dec; 310(5753):1425-6; author reply 1425-6. PubMed ID: 16329172
    [No Abstract]   [Full Text] [Related]  

  • 54. [The world population does not have the drugs it needs. WHO report recommends more stringent control of the drug industry].
    Asplund K
    Lakartidningen; 2005 Feb 14-20; 102(7):450-1. PubMed ID: 15768693
    [No Abstract]   [Full Text] [Related]  

  • 55. Pharmageddon.
    Isaacs D
    J Paediatr Child Health; 2009 Sep; 45(9):479-80. PubMed ID: 19761480
    [No Abstract]   [Full Text] [Related]  

  • 56. [Drug shortage: determinants, consequences and management].
    Reis AM; Perini E
    Cien Saude Colet; 2008 Apr; 13 Suppl():603-10. PubMed ID: 21936164
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Study group: Organization and Economics of Drug Supply. 2].
    Baumann D
    Pharm Prax; 1968; 8():177-82. PubMed ID: 5711290
    [No Abstract]   [Full Text] [Related]  

  • 58. [Ascending curves of new products: an instrument of marketing].
    Barocco V
    Boll Chim Farm; 1976 Jul; 115(7):529-37. PubMed ID: 1016609
    [No Abstract]   [Full Text] [Related]  

  • 59. Management of quality, capacity, and productivity at Merck.
    Nathan J; Venkataraman R
    Hosp Mater Manage Q; 1999 Feb; 20(3):64-9. PubMed ID: 10345635
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Theoretical problems in drug circulation].
    Vlćková J; Solich J
    Pharm Prax; 1972; 11():248-50. PubMed ID: 4649576
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.